Identification of novel long non‑coding RNA in diffuse intrinsic pontine gliomas by expression profile analysis

Liu,Yuehui; Liu,Haiping; Zhang,Dongwei

doi:10.3892/ol.2018.9461

Identification of novel long non‑coding RNA in diffuse intrinsic pontine gliomas by expression profile analysis

Authors:
- Yuehui Liu
- Haiping Liu
- Dongwei Zhang
View Affiliations

Affiliations: Department of Neurology, The Affiliated Hospital of Inner Mongolia University for The Nationalities, Tongliao, Inner Mongolia 028007, P.R. China, College of Life Science, Inner Mongolia University for The Nationalities, Tongliao, Inner Mongolia 028000, P.R. China
Published online on: September 19, 2018 https://doi.org/10.3892/ol.2018.9461
Pages: 6401-6406
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diffuse intrinsic pontine glioma (DIPG) is one of the most devastating types of pediatric cancer. Accumulating evidence suggests that the dysregulated expression of long non‑coding (lnc)‑RNAs is associated with various pathologies of the CNS. However, the expression patterns and prognostic roles of lncRNAs in DIPG have not yet been systematically determined. In the present study, lncRNA expression profiles were obtained from the Gene Expression Omnibus (GEO) database using the lncRNA‑mining approach and a differential expression analysis for lncRNAs was performed between DIPG and low‑grade brainstem glioma and DIPG and normal pediatric brainstem tissue. Using a two‑tailed t‑test, 58 and 197 lncRNAs were found to be significantly deferentially expressed (Fold change >2 or <0.5, FDR adjusted P<0.05). To identify the prognostic value of these 255 differentially expressed lncRNAs, univariate and multivariate Cox proportional hazards regression analysis were performed and a 9‑lncRNA signature as a potential biomarker for predicting the prognosis of DIPG was constructed. Kaplan‑Meier curve analysis showed that patients in the high‑risk group exhibited a reduced survival time compared with patients in the low‑risk group (median survival of 230 vs. 460 days, log‑rank test P<0.001). Moreover, this lncRNA‑signature could be used as an independent prognostic marker for DIPG patient survival. The present study provided novel candidates for the investigation of potential diagnostic or prognostic biomarkers and/or therapeutic targets of DIPG, as well as a novel insight into the underlying mechanisms of DIPG.

View Figures

View References

1	Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, da Silva NS, et al: Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol. 29:3999–4006. 2011. View Article : Google Scholar : PubMed/NCBI
2	Korones DN: Treatment of newly diagnosed diffuse brain stem gliomas in children: In search of the holy grail. Expert Rev Anticancer Ther. 7:663–674. 2007. View Article : Google Scholar : PubMed/NCBI
3	Jansen MH, van Vuurden DG, Vandertop WP and Kaspers GJ: Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology. Cancer Treat Rev. 38:27–35. 2012. View Article : Google Scholar : PubMed/NCBI
4	Bredlau AL and Korones DN: Diffuse intrinsic pontine gliomas: Treatments and controversies. Adv Cancer Res. 121:235–259. 2014. View Article : Google Scholar : PubMed/NCBI
5	Stein LD: Human genome: End of the beginning. Nature. 431:915–916. 2004. View Article : Google Scholar : PubMed/NCBI
6	Brosnan CA and Voinnet O: The long and the short of noncoding RNAs. Curr Opin Cell Biol. 21:416–425. 2009. View Article : Google Scholar : PubMed/NCBI
7	Spizzo R, Almeida MI, Colombatti A and Calin GA: Long non-coding RNAs and cancer: A new frontier of translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
8	Kornienko AE, Guenzl PM, Barlow DP and Pauler FM: Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI
9	Cao J: The functional role of long non-coding RNAs and epigenetics. Biol Proced Online. 16:112014. View Article : Google Scholar : PubMed/NCBI
10	Zhou M, Wang X, Li J, Hao D, Wang Z, Shi H, Han L, Zhou H and Sun J: Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. Mol Biosyst. 11:760–769. 2015. View Article : Google Scholar : PubMed/NCBI
11	Sun J, Shi H, Wang Z, Zhang C, Liu L, Wang L, He W, Hao D, Liu S and Zhou M: Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. Mol Biosyst. 10:2074–2081. 2014. View Article : Google Scholar : PubMed/NCBI
12	Zhou M, Wang X, Shi H, Cheng L, Wang Z, Zhao H, Yang L and Sun J: Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611. 2016.PubMed/NCBI
13	Zhou M, Sun Y, Sun Y, Xu W, Zhang Z, Zhao H, Zhong Z and Sun J: Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer. Oncotarget. 7:32433–32448. 2016.PubMed/NCBI
14	Zhou M, Zhao H, Wang Z, Cheng L, Yang L, Shi H, Yang H and Sun J: Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma. J Exp Clin Cancer Res. 34:1022015. View Article : Google Scholar : PubMed/NCBI
15	Zhou M, Zhao H, Xu W, Bao S, Cheng L and Sun J: Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer. 16:162017. View Article : Google Scholar : PubMed/NCBI
16	Tang JY, Lee JC, Chang YT, Hou MF, Huang HW, Liaw CC and Chang HW: Long noncoding RNAs-related diseases, cancers and drugs. ScientificWorldJournal. 2013:9435392013. View Article : Google Scholar : PubMed/NCBI
17	Zhou M, Zhang Z, Zhao H, Bao S and Sun J: A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma. BMC Cancer. 18:392018. View Article : Google Scholar : PubMed/NCBI
18	Qureshi IA, Mattick JS and Mehler MF: Long non-coding RNAs in nervous system function and disease. Brain Res. 1338:20–35. 2010. View Article : Google Scholar : PubMed/NCBI
19	Zhou M, Zhang Z, Zhao H, Bao S, Cheng L and Sun J: An immune-related six-lncRNA signature to improve prognosis prediction of glioblastoma multiforme. Mol Neurobiol. 55:3684–3697. 2017.PubMed/NCBI
20	Fan Y, Wang YF, Su HF, Fang N, Zou C, Li WF and Fei ZH: Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition. J Hemat Oncol. 9:572016. View Article : Google Scholar
21	Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian J, Zhang X and Fang JY: A long non-coding RNA signature to improve prognosis prediction of colorectal cancer. Oncotarget. 5:2230–2242. 2014. View Article : Google Scholar : PubMed/NCBI
22	Pang KC, Stephen S, Engstrom PG, Tajul-Arifin K, Chen W, Wahlestedt C, Lenhard B, Hayashizaki Y and Mattick JS: RNAdb-a comprehensive mammalian noncoding RNA database. Nucleic Acids Res. 33(Database Issue): D125–D130. 2005. View Article : Google Scholar : PubMed/NCBI
23	Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z and Galon J: ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 25:1091–1093. 2009. View Article : Google Scholar : PubMed/NCBI
24	da Huang W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
25	Warren KE: Diffuse intrinsic pontine glioma: Poised for progress. Front Oncol. 2:2052012. View Article : Google Scholar : PubMed/NCBI
26	Zhang S, Feng X, Koga H, Ichikawa T, Abe S and Kumanishi T: p53 gene mutations in pontine gliomas of juvenile onset. Biochem Biophys Res Commun. 196:851–857. 1993. View Article : Google Scholar : PubMed/NCBI
27	Lulla RR, Laskowski J, Goldman S, Gopalakrishnan V and Fangusaro J: Microrna profiling reveals two subgroups of diffuse intrinsic pontine glioma. Neuro-Oncology. 16:i40–i59. 2014.
28	Kleinschmidt-DeMasters BK and Mulcahy Levy JM: H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Clin Neuropathol. 37:53–63. 2018. View Article : Google Scholar : PubMed/NCBI
29	Harries LW: Long non-coding RNAs and human disease. Biochem Soc Trans. 40:902–906. 2012. View Article : Google Scholar : PubMed/NCBI
30	Ma H, Hao Y, Dong X, Gong Q, Chen J, Zhang J and Tian W: Molecular mechanisms and function prediction of long noncoding RNA. ScientificWorldJournal. 2012:5417862012. View Article : Google Scholar : PubMed/NCBI
31	Fernandez-Medarde A and Santos E: Ras in cancer and developmental diseases. Genes Cancer. 2:344–358. 2011. View Article : Google Scholar : PubMed/NCBI
32	Yu JS and Cui W: Proliferation, survival and metabolism: The role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development. 143:3050–3060. 2016. View Article : Google Scholar : PubMed/NCBI
33	Wang L, Zhou K, Fu Z, Yu D, Huang H, Zang X and Mo X: Brain development and Akt signaling: The crossroads of signaling pathway and neurodevelopmental diseases. J Mol Neurosci. 61:379–384. 2017. View Article : Google Scholar : PubMed/NCBI